Clinical trials
Proteinuria trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Bayer | 2 |
| Rennes University Hospital | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Centre Hospitalier Intercommunal André Grégoire | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Proteinuria | 22 |
| Renal Insufficiency, Chronic | 4 |
| Glomerulonephritis, IGA | 3 |
| Diabetes Mellitus | 2 |
| Fabry Disease | 2 |
| Kidney Failure, Chronic | 2 |
| Renal Insufficiency | 2 |
| Acidosis, Lactic | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Albuminuria | 1 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.